pneumocandin a(0) has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzo, G; Balkovec, JM; Bartizal, K; Black, RM; McFadden, DC; Nollstadt, K; Powles, MA; Schmatz, DM | 1 |
| Abruzzo, GK; Fromtling, RA | 1 |
2 other study(ies) available for pneumocandin a(0) and Extravascular Hemolysis
| Article | Year |
|---|---|
Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; beta-Glucans; Candida albicans; Cell Membrane; Disease Models, Animal; Echinocandins; Erythrocytes; Glucans; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mitosporic Fungi; Peptides; Peptides, Cyclic; Pneumocystis; Structure-Activity Relationship | 1992 |
L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echinocandins; Erythrocytes; Female; Hemolysis; Kidney; Liver; Mice; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1989 |